cosinuss° joins DiME’s DATAcc project “Building the Business Case for Digital Endpoints” to revolutionize clinical trials
Posted:
DATAcc by DiMe launches its new project, “Building the Business Case for Digital Endpoints,” aimed at advancing the adoption of digital health measures in clinical trials. Read the full article here.
A study suggests that artificial intelligence (AI) showed comparable performance to dermatologists in detecting melanoma, with similar sensitivity and specificity in prospective clinical studies.
Experts often consider melanoma to be the most serious type of skin cancer due to the likelihood of metastasizing.
Read more here.
The further Apple dives into medical technology, the more it will have to deal with regulators. Now, the App Store will label apps that meet select criteria for medical devices in the US, EU, and UK.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us